The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDebenhams Regulatory News (DEB)

  • There is currently no data for DEB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Debenhams plc

2 Apr 2019 12:00

RNS Number : 8363U
Stifel Nicolaus Europe Limited
02 April 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Stifel Nicolaus Europe Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Debenhams plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Stifel is Broker to Debenhams plc

(d) Date dealing undertaken:

01 April 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Buy

670,629

2.7 GBx

2.7 GBx

Ordinary

Sell

670,629

2.7 GBx

2.7 GBx

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

02 April 2019

Contact name:

Vijay Odedra

Telephone number:

020 7710 7621

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERSSESUEFUSEFL
Date   Source Headline
1st Mar 20174:48 pmRNSHolding(s) in Company
28th Feb 20179:56 amRNSTotal Voting Rights
28th Feb 20179:54 amRNSHolding(s) in Company
27th Feb 201711:25 amRNSDirector/PDMR Shareholding
27th Feb 201710:26 amRNSChange in Director's external directorships
27th Feb 20179:00 amRNSChange in Director's external directorships
23rd Feb 20172:44 pmRNSChange in Directors External Directorship
15th Feb 201710:53 amRNSHolding(s) in Company
13th Feb 201711:39 amRNSHolding(s) in Company
31st Jan 201711:04 amRNSTotal Voting Rights
20th Jan 201710:38 amRNSHolding(s) in Company
18th Jan 20171:00 pmRNSHolding(s) in Company
12th Jan 20174:11 pmRNSAGM Results
12th Jan 20177:00 amRNSChristmas Trading Update
11th Jan 201712:07 pmRNSHolding(s) in Company
3rd Jan 20179:29 amRNSTotal Voting Rights
29th Dec 20163:16 pmRNSHolding(s) in Company
23rd Dec 201611:27 amRNSBlock listing Interim Review
23rd Dec 201611:25 amRNSBlock listing Interim Review
30th Nov 201610:06 amRNSTotal Voting Rights
22nd Nov 20169:45 amRNSHolding(s) in Company
21st Nov 20162:19 pmRNSAnnual Report and Associated Documents
15th Nov 20169:06 amRNSDirectorate Change
10th Nov 201610:13 amRNSDirector/PDMR Shareholding
7th Nov 20164:34 pmRNSHolding(s) in Company
31st Oct 20169:57 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSFull Year Results
17th Oct 20161:48 pmRNSDirectorate Change
3rd Oct 201610:27 amRNSTotal Voting Rights
6th Sep 20169:30 amRNSBoard Appointment
1st Sep 20161:35 pmRNSTotal Voting Rights
2nd Aug 20169:08 amRNSTotal Voting Rights
25th Jul 20161:51 pmRNSNotification of Major Interests in Shares
19th Jul 20164:06 pmRNSHolding(s) in Company
13th Jul 20164:47 pmRNSHolding(s) in Company
13th Jul 201612:06 pmRNSHolding(s) in Company
7th Jul 20164:31 pmRNSDirector/PDMR Shareholding
7th Jul 20164:27 pmRNSDirector/PDMR Shareholding
7th Jul 20164:26 pmRNSDirector/PDMR Shareholding
1st Jul 20169:35 amRNSTotal Voting Rights
29th Jun 20165:15 pmRNSHolding(s) in Company
29th Jun 20163:52 pmRNSBlock listing Interim Review
29th Jun 20163:50 pmRNSBlock listing Interim Review
29th Jun 20169:52 amRNSHolding(s) in Company
23rd Jun 20165:48 pmRNSDirector/PDMR Shareholding
23rd Jun 20162:03 pmRNSHolding(s) in Company
23rd Jun 20169:58 amRNSHolding(s) in Company
22nd Jun 20167:00 amRNSTrading Update
7th Jun 20165:37 pmRNSHolding(s) in Company
7th Jun 20165:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.